Crude Oil Moves Lower; CarMax Posts Downbeat Earnings
Portfolio Pulse from Lisa Levin
U.S. stocks traded higher with the Nasdaq Composite gaining 1%. CarMax Inc reported weaker-than-expected earnings for its second quarter with a revenue decline of 13.2% YoY to $7.07 billion. Bionomics Limited shares shot up 247% after the ATTUNE trial met its primary endpoint. Baudax Bio, Inc. shares boosted by 86% after the FDA granted orphan drug designation for TI-168. Chico's FAS, Inc. shares were up by 62% following its acquisition by Sycamore Partners. Ascent Solar Technologies, Inc. shares dropped 62% after announcing pricing of a public offering of units. Brainstorm Cell Therapeutics Inc. shares were down 54% after the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for ALS treatment. GigaCloud Technology Inc. fell 26% after Culper Research issued a short report on the stock.
September 28, 2023 | 3:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ascent Solar Technologies, Inc. shares dropped 62% after announcing pricing of a public offering of units.
The announcement of a public offering of units could negatively impact Ascent Solar's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Brainstorm Cell Therapeutics Inc. shares were down 54% after the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for ALS treatment.
The FDA Advisory Committee's vote could negatively impact Brainstorm Cell's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
GigaCloud Technology Inc. fell 26% after Culper Research issued a short report on the stock.
The short report by Culper Research could negatively impact GigaCloud Technology's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
CarMax reported weaker-than-expected earnings for its second quarter with a revenue decline of 13.2% YoY.
CarMax's weaker-than-expected earnings and revenue decline could negatively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Bionomics Limited shares shot up 247% after the ATTUNE trial met its primary endpoint.
The successful ATTUNE trial results could positively impact Bionomics' stock price in the short term.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Baudax Bio, Inc. shares boosted by 86% after the FDA granted orphan drug designation for TI-168.
The FDA's orphan drug designation for TI-168 could positively impact Baudax Bio's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Chico's FAS, Inc. shares were up by 62% following its acquisition by Sycamore Partners.
The acquisition by Sycamore Partners could positively impact Chico's FAS's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100